Broker Tips
Berenberg slashes target price on Burford Capital, downgrades to 'hold'
Analysts at Berenberg absolutely slashed their price target on finance firm Burford Capital from 2,070p to 810p on Wednesday following a "tough six months" for the group.
Read full storyBroker tips: Equiniti, EasyJet, Burford Capital
Analysts at Barclays cut their target price for Equiniti's shares on the heels of weaker UK macroeconomic conditions that hit its Pensions arm in the second half of the year, falling interest rates in the States and the drag from foreign exchange rates.
Read full storyWednesday broker round-up
Burford Capital: Berenberg downgrades to hold with a target price of 810p.
Read full storyBarclays slashes target price for Equiniti as margins and cash flow disappoint
Analysts at Barclays cut their target price for Equiniti's shares on the heels of weaker UK macroeconomic conditions that hit its Pensions arm in the second half of the year, falling interest rates in the States and the drag from foreign exchange rates.
Read full storyCanaccord raises target price for EasyJet substantially, but stays at 'hold'
Analysts at Canaccord Genuity revised their target price for easyJet substantially higher to reflect the company's modest fleet expansion in the coming years and, at least in the near-term, heightened industry-wide discipline when it comes to adding capacity.
Read full storyBroker tips: Jadestone Energy, Forterra, Ibstock, Lloyds
Analysts at Berenberg upped their target price on upstream oil and gas firm Jadestone Energy on Tuesday following the group's acquisition of a 69% working interest in the Maari project in the Taranaki Basin, offshore New Zealand.
Read full storyCanaccord Genuity sees 'attractive' shareholder value in Forterra and Ibstock
Cannacord Genuity initiated coverage of shares in Forterra and Ibstock with 'buy' and 'hold' recommendations, respectively, telling clients their expectation was for both companies to "deliver attractive profitability and returns for the foreseeable future".
Read full storyMorgan Stanley shows preference for Lloyds among UK listed lenders
Analysts at Morgan Stanley upgraded their view on European lenders' shares, including for the various London-listed banks, from 'in-line' to 'attractive'.
Read full storyBerenberg ups target price on Jadestone Energy
Analysts at Berenberg upped their target price on upstream oil and gas firm Jadestone Energy on Tuesday following the group's acquisition of a 69% working interest in the Maari project in the Taranaki Basin, offshore New Zealand.
Read full storyTuesday broker round-up
B&M: Citigroup downgrades to neutral with a target price of 405p.
Read full storyMonday broker round-up
Croda International: Liberum Capital downgrades to hold with a target price of 4,400p.
Read full storyBroker tips: HSBC, Vodafone, Consort Medical
Analysts at Jefferies upgraded their recommendation for shares of HSBC from 'hold' to 'buy' in anticipation of an uplift to the lender's return on capital as it restructured some of its operations.
Read full storyBerenberg hails Vodafone's move towards Open RAN technology
Analysts at Berenberg reiterated their 'buy' recommendation for shares of Vodafone following the company's announcement that it was studying a possible redesign of all its European cell sites based on so-called Open RAN technology which the analysts said could yield multiple benefits, including sharply reduced operating and capital expenditure costs.
Read full storyJefferies upgrades HSBC to 'buy' on restructuring plans
Analysts at Jefferies upgraded their recommendation for shares of HSBC from 'hold' to 'buy' in anticipation of an uplift to the lender's return on capital as it restructured some of its operations.
Read full storyShoreCap downgrades Consort Medical to 'hold' after all-cash offer from Recipharm
Analysts at ShoreCap downgraded their recommendation for shares of Consort Medical from 'buy' to 'hold' following the recommended cash offer from Recipharm.
Read full storyFriday broker round-up
Whitbread: Barclays upgrades to overweight with a target price of 4,900p.
Read full storyShoreCap stays at 'buy' on AstraZeneca after EU approves Qtrilmet
Analysts at ShoreCap reiterated their 'buy' recommendation on shares of AstraZeneca following news that Brussels had approved its Qtrilmet treatment for controlling blood sugar levels in patients suffering from Type-2 diabetes.
Read full storyCannacord cuts Weir Group target due to extended weakness in oil and gas sector
Analysts at Cannacord Genuity cut their target price on shares of Weir Group to reflect to reflect a now more sombre outlook for only a "modest recovery over an extended period" in the company's oil and gas operations.
Read full storyBroker tips: Capital & Counties, Taylor Wimpey, Tullow Oil
Peel Hunt upgraded its stance on shares of Capital & Counties to 'buy' from 'add' on Thursday, lifting the price target to 300p from 280p as it pointed to "significant upside" from a double disposal.
Read full storyCanaccord drops Tullow Oil to 'speculative buy'
Analysts at Canaccord Genuity lowered their rating on Tullow Oil from 'buy' to 'speculative buy' on Thursday following a disappointing trading update from the firm in the previous session.
Read full story